View |
|
DR-XY28753
|
Risperidone
|
Risperdal Consta
|
50 mg
|
Prolonged-Release Powder For Injection (Im)
|
Antipsychotic
|
Alkemes Conrolled Therspeutics II
|
U.S.A.
|
Automatic Renewal
|
23 June 2023
|
07 July 2028
|
View |
|
DR-XY28754
|
Risperidone
|
Risperdal Consta
|
37.5 mg
|
Prolonged-Release Powder For Injection (Im)
|
Antipsychotic
|
Alkemes Conrolled Therspeutics II
|
U.S.A.
|
Automatic Renewal
|
08 July 2023
|
07 July 2028
|
View |
|
DR-XY28755
|
Risperidone
|
Risperdal Consta
|
25 mg
|
Prolonged-Release Powder For Suspension For Injection (Im)
|
Antipsychotic
|
Alkemes Conrolled Therspeutics II
|
U.S.A.
|
Automatic Renewal
|
25 July 2023
|
07 July 2028
|
View |
|
DR-XY28759
|
Ciprofloxacin
|
Cirok
|
2 mg/mL
|
Solution For IV Infusion
|
Antibacterial (Fluoroquinolone)
|
Korea United Pharm Inc.
|
Korea
|
Automatic Renewal
|
10 March 2023
|
09 July 2028
|
View |
|
DR-XY28774
|
Calcitriol
|
Osteomeg
|
0.25 mcg
|
Softgel Capsule
|
-
|
Mega Lifesciences Public Company Limited
|
Thailand
|
-
|
31 January 2022
|
11 July 2025
|
View |
DR-XY28803_PI_01_NO RX SYMBOL.pdf
|
DR-XY28803
|
Brimonidine tartrate
|
Unbranded
|
1.5 mg/mL (0.15%)
|
Sterile Ophthamic Solution
|
Antiglaucoma Preparation and Miotic (Sympathomimetic in glaucoma therapy)
|
Allergan Pharmaceuticals Ireland
|
Ireland
|
Renewal
|
10 March 2024
|
21 July 2029
|
View |
|
DR-XY28808
|
Valganciclovir (As Hydrochloride)
|
Valcyte
|
450 mg
|
Film Coated Tablet
|
Antiviral (Nucleosides and nucleotides excluding reverse transcriptase inhibitors)
|
Patheon Inc.
|
Canada
|
Automatic Renewal
|
27 October 2022
|
21 January 2028
|
View |
|
DR-XY28817
|
Furosemide
|
Diuspec
|
40 mg
|
Tablet
|
Diuretic
|
Hizon Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
06 June 2023
|
24 July 2028
|
View |
|
DR-XY28822
|
Co-Amoxiclav
|
Claventin
|
625 mg
|
Tablet
|
Antibacterial (Penicillin)
|
Pt. Dankos Farma
|
Indonesia
|
Renewal
|
19 April 2024
|
28 July 2028
|
View |
|
DR-XY28837
|
Prednisone
|
Prolix
|
10 mg/5 mL
|
Suspension
|
Corticosteroid
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
21 June 2023
|
28 July 2028
|
View |
|
DR-XY28840
|
Fenofibrate
|
Lipway SR
|
250 mg
|
Sustained-Release Capsule
|
Lipid Modifying Agent (Fibrate)
|
SwissPharma Research Laboratories Inc.
|
Philippines
|
Automatic Renewal
|
12 April 2023
|
29 July 2028
|
View |
|
DR-XY28847
|
TIMOLOL MALEATE
|
Unbranded
|
0.5% w / v
|
Sterile Ophthalmic Solution
|
Antiglaucoma Preparation and Miotic
|
Ashford Pharmaceutical Laboratories, Inc.
|
Philippines
|
Renewal
|
13 May 2023
|
07 August 2028
|
View |
|
DR-XY28861
|
LORATADINE
|
LORATYNE
|
10 mg
|
Film - Coated Tablet
|
H1 - RECEPTOR ANTAGONIST (ANTIHISTAMINE)
|
Hua Shin Chemical Pharm'l Work Co., Ltd.
|
Taiwan
|
Renewal
|
21 May 2019
|
08 August 2028
|
View |
|
DR-XY28879
|
Ampicillin (as sodium)
|
Pentracin
|
500mg
|
Powder for Injection (IM/IV)
|
-
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
-
|
16 February 2021
|
20 August 2025
|
View |
|
DR-XY28881
|
Levofloxacin
|
Oftaquix
|
5 mg/mL
|
Ophthalmic Solution
|
Antibacterial (Quinolone)
|
Santen Pharmaceutical Co., Ltd. (Noto plant)
|
Japan
|
Automatic Renewal
|
17 March 2023
|
20 August 2028
|
View |
|
DR-XY28890
|
Salbutamol + Guaifenesin
|
Venzadril
|
50mg / 1 mg per 5 mL
|
Syrup
|
Expectorant/ Antiasthma (Bronchodilator)
|
Hizon Laboratories, Inc.
|
Philippines
|
Renewal
|
04 August 2023
|
21 August 2028
|
View |
|
DR-XY28902
|
Ketotifen (As Fumarate)
|
Azimef
|
1 mg/5 mL
|
Syrup
|
Antihistamine
|
Y.S.P. Industries (M) Sdn. Bhd.
|
Malaysia
|
Automatic Renewal
|
26 July 2023
|
27 August 2028
|
View |
|
DR-XY28903
|
Sodium Chloride
|
Hypersalt
|
5%
|
Ophthalmic Solution
|
Ophthalmologicals
|
E.L. Laboratories, Inc.
|
Philippines
|
Renewal
|
03 May 2022
|
16 April 2027
|
View |
|
DR-XY28913
|
Guiafenesin
|
Robitussin
|
200 mg
|
Softgel Capsule
|
Expectorant
|
Catalent Australia Pty. Ltd.
|
Australia
|
Automatic Renewal (OTC)
|
23 June 2023
|
02 September 2028
|
View |
|
DR-XY28916
|
Rifampicin + Isoniazid + Ethambutol Hydrochloride
|
Tritab
|
150 mg/75 mg/275 mg
|
Film-Coated Tablet
|
Antituberculosis
|
Amherst Laboratories, Inc.
|
Philippines
|
Renewal
|
24 June 2022
|
28 August 2027
|